UD's Terry Papoutsakis has been selected to receive the Daniel I.C. Wang Award for excellence in biochemical engineering from the American Institute of Chemical Engineers' Society for Biological Engineering.

Biochemical engineering excellence

UD's Papoutsakis to receive Daniel I.C. Wang Award from AIChE

TEXT SIZE

10:41 a.m., Sept. 25, 2013--Terry Papoutsakis, Eugene du Pont Professor of Chemical and Biomolecular Engineering at the University of Delaware, has been selected to receive the Daniel I.C. Wang Award for excellence in biochemical engineering from the American Institute of Chemical Engineers Society for Biological Engineering.

Papoutsakis, who is affiliated with the Delaware Biotechnology Institute, is cited for pioneering the genetic exploration of clostridia, anaerobic bacteria that are ubiquitous in soil and can cause infections in wounds. 

Honors Stories

Boer Medal awarded

Antonio Luque, director of the Institute of Solar Energy at the Technical University of Madrid, Spain, will receive the Karl W. Boer Solar Energy Medal of Merit, established by the distinguished UD scientist.

Winning simulation

SimuTrach, a device that provides realistic training for the care of tracheostomy patients, has been selected as the first-place technology innovation winner by the 15th International Meeting on Simulation in Healthcare Scientific Content Committee.

He is also credited with cell culture engineering leading to the development of technologies for the production of protein therapeutics and viral vaccines, as well as immunotherapies.

“In addition, he pioneered hematopoietic stem-cell bioengineering when the potential of stem-cell therapies was hardly on anyone’s radar screen,” says Wildred Chen, Gore Professor of Chemical and Biomolecular Engineering, who nominated Papoutsakis for the award.

Papoutsakis will receive the award and deliver the Daniel I.C. Wang Award Lecture at the AIChE annual meeting in San Francisco on Nov. 4.

His talk, “Force to Death and New Life, Some with Programming Vitality,” will address regenerative medicine — the quest to provide biological or hybrid synthetic-biological materials that can enable or facilitate therapeutic interventions, from transfusions and gene therapy to organ replacement. His work has shown that megakaryocyte-derived microparticles have an extraordinary ability to program stem and progenitor cells and therefore have potential use in regenerative-medicine applications.

A graduate of the National Technical University of Athens, Papoutsakis received his master's and doctoral degrees from Purdue University. His research focuses on areas of systems biology, metabolic engineering, experimental and computational genomics with applications in stem-cell biology, and prokaryotic biology for the production of biofuels and chemicals from biomass.

About the Daniel I.C. Wang Award 

The award was launched in 2012 to recognize Wang, a professor at MIT who has made significant contributions to education and research in biochemical engineering as well as technological innovations in bioprocessing.

Selection of awardees is based on innovation through research, education, or practice of biochemical engineering; successful development of new products, processes or services; research at the interface of biological science and engineering; significant publication, patents, or technology development in the field; and demonstrated economic or societal impact through innovation or practice of biochemical engineering.

Article by Diane Kukich

Photo by Kathy F. Atkinson

icon-fb icon-tw icon-yt icon-fs
ADVERTISEMENT

News Media Contact

University of Delaware
Communications and Public Affairs
302-831-NEWS
publicaffairs@udel.edu

UDaily is produced by
Communications and Public Affairs

The Academy Building
105 East Main Street
University of Delaware
Newark, DE 19716 | USA
Phone: (302) 831-2792
email: publicaffairs@udel.edu
www.udel.edu/cpa
University of Delaware • Newark, DE 19716
publicaffairs@udel.edu • (302) 831-2792 • ©2012
University of Delaware • Newark, DE 19716 • USA • Phone: (302) 831-2792 • © 2013
Comments|Contact Us|Legal Notices